COVID-19 has catalyzed a paradigm shift in the way healthcare providers (HCPs) interact with both patients and pharma companies – and with lasting impact. Healthcare providers opine that there is great value in increased virtual interactions.
The vast majority of HCPs have seen pharma companies change what they communicate about, delivering not just product information but support that meets their most pressing needs. Health care providers also opine that the services pharma companies are offering now are of higher value than before Covid 19.
Download this white paper to know about our experience working with our long-standing clients to implement innovative digital strategies as they rapidly respond to the shifting trends during the Covid 19 pandemic.
Comments
Comments